Clinical Trial Update: Darbepoetin in Neonatal Encephalopathy Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for darbepoetin in neonatal encephalopathy; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Encephalopathy

Drugs mentioned

• Darbepoetin (darbepoetin alfa)

Snippet

Sponsor: Imperial College London | Conditions: Neonatal Encephalopathy | Phase 2 | Status: UNKNOWN